Skip to main content

Advertisement

Log in

Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases

  • Case Report
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Indium-111 pentetreotide scintigraphy was performed in two patients for the localization of recurrent medullary thyroid carcinoma treated by surgery and external radiotherapy 1 and 10 years earlier. A marked uptake of the radiopharmaceutical was demonstrated in the lung areas that had been irradiated. These cases strongly suggest that this uptake is related to pulmonary fibrosis, a well-known complication of radiotherapy, even long after the irradiation. Therefore, attention must be paid to the avoidance of false-positive interpretation of somatostatin receptor scintigraphy in patients previously treated by radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hoefnagel CA, Delprat CC, Zanin D, van der Schoot JB. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.Clin Nucl Med 1988; 13: 159–165.

    Google Scholar 

  2. Kwekkeboom DJ, Reubi JC, Lamberts SWJ, Bruining HA, Mulder AH, Oei HY, Krenning EP. In vivo somatostatin receptor imaging in medullary thyroid carcinoma.J Clin Endocrinol Metab 1993; 76: 1413–1417.

    Google Scholar 

  3. Dörr U, Würstlin S, Frank-Raue K, Raue F, Hehrmann R, Iser G, Scholz M, Guhl L, Buhr HJ, Bihl H. Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma; a comparative study.Horm Metab Res Suppl 1993; 27: 48–55.

    Google Scholar 

  4. Berná L, Cabezas R, Mora J, Torres G, Estorch M, Carrió I.111In-octreotide and99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.J Endocrinol 1995; 144: 339–345.

    Google Scholar 

  5. Phillips TL, Wyatt JP. Radiation fibrosis. In; Fishman AP, ed.Pulmonary diseases and disorders. New York; McGraw-Hill; 1980:658–674.

    Google Scholar 

  6. Delanian S, Martin M, Housset M. La fibrose iatrogénique en cancérologie (Ire partie); aspects descriptifs et physiopathologiques. Bull Cancer (Paris) 1993; 80: 192–201.

    Google Scholar 

  7. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis.N Engl J Med 1987; 317: 202–209.

    Google Scholar 

  8. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ. Distinct subsets of somatostatin receptors on cultured human lymphocytes.J Biol Chem 1989; 264: 949–953.

    Google Scholar 

  9. Bhatena SJ, Louie J, Schechter GP, Redman RS, Wahl L, Recant L. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon.Diabetes 1981; 30:127–131.

    Google Scholar 

  10. Renold FK, Dazin P, Goetzl EJ, Payan DG. Interleukin-3 modulation of mouse bone marrow derived mast cell receptors for somatostatin.J Neurosci Res 1987; 18: 195–202.

    Google Scholar 

  11. Vanhagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, van den Anker-Lugtenburg PJ, Löwenberg B, Lamberts SWJ. Somatostatin and the immune and haematopoetic system; a review.Eur J Clin Invest 1994; 24: 91–99.

    Google Scholar 

  12. Reubi J-C. Neuropeptide receptors in health and disease; the molecular basis for in vivo imaging.J Nucl Med 1995; 36; 1825–1835.

    Google Scholar 

  13. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HY, van Hagen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide; the Rotterdam experience with more than 1000 patients.Eur J Nucl Med 1993; 20: 716–731.

    Google Scholar 

  14. Valdés Olmos RA, Boersma LJ, van Zandwijk N, Hoefnagel CA, Lebesque JV.111ln-pentetreotide for the detection of radiation pneumonitis [abstract].Eur J Nucl Med 1994; 21: 836.

    Google Scholar 

  15. Gross NJ. Pulmonary effects of radiation therapy.Ann Intern Med 1977; 86: 81–92.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoffel, M., Jamar, F., Donckier, J. et al. Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases. Eur J Nucl Med 23, 723–726 (1996). https://doi.org/10.1007/BF00834537

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00834537

Key words

Navigation